ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

HCM Hutchmed (china) Limited

290.00
-14.00 (-4.61%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Hutchmed (china) Limited HCM ロンドン Ordinary Share
  前日比 前日比 % 現在値 時刻
-14.00 -4.61% 290.00 00:22:23
始値 安値 高値 終値 前日終値
312.00 287.00 312.00 290.00 304.00
この銘柄の詳細情報 »
業種
PHARMACEUTICALS & BIOTECHNOLOGY

最新ニュース

日付 時間 ソース タイトル
2024/4/2700:09ALNCNewsHutchmed notes CHMP's positive opinion for fruiquintinib..
2024/4/2621:30UK RNSHutchmed (China) Limited Positive CHMP Opinion for..
2024/4/2217:30UK RNSHutchmed (China) Limited Vesting of Awards Under the LTIP
2024/4/0817:30UK RNSHutchmed (China) Limited 2023 Annual Report and Notice of..
2024/4/0517:30UK RNSHutchmed (China) Limited Data to be Presented at AACR..
2024/4/0218:32ALNCNewsHutchmed endometrial cancer treatment application accepted..
2024/4/0215:00UK RNSHutchmed (China) Limited HUTCHMED and Innovent Announce NDA..
2024/3/2820:08ALNCNewsHutchmed lung cancer treatment accepted for review in China
2024/3/2816:00UK RNSHutchmed (China) Limited Savolitinib sNDA Accepted in China
2024/3/2219:09ALNCNewsHutchmed begins registration stage for sovleplenib phase 2/3..
2024/3/2216:16ALNCNews*CORRECT: Hutchmed China initiates registration for phase 3..
2024/3/2216:00UK RNSHutchmed (China) Limited Initiation of Registration Stage of..
2024/3/1418:00UK RNSHutchmed (China) Limited LTIP and Share Option Scheme
2024/3/0517:30UK RNSHutchmed (China) Limited Vesting of awards under the LTIP
2024/2/2902:31ALNCNewsEARNINGS: Hutchmed revenue surges, Craven House's loss..
2024/2/2821:45UK RNSHutchmed (China) Limited Publication of Form 20-F
2024/2/2820:30UK RNSHutchmed (China) Limited 2023 Full Year Results and Business..
2024/2/0718:50ALNCNewsHutchmed hails fruquintinib trial results for gastric cancer..
2024/2/0716:00UK RNSHutchmed (China) Limited Presentation of Phase III Data on..
2024/2/0218:52ALNCNewsHutchmed says Inmagene exercises option to licence drug..
2024/2/0217:37UK RNSHutchmed (China) Limited Inmagene Exercises Option for Two..
2024/2/0117:30UK RNSHutchmed (China) Limited HUTCHMED to Announce 2023 Final..
2024/1/3018:20ALNCNewsHutchmed celebrates cancer drug approval in hometown of Hong..
2024/1/3016:12UK RNSHutchmed (China) Limited HUTCHMED Receives Marketing..
2024/1/1119:17ALNCNewsTOP NEWS: Hutchmed Sovleplenib accepted for review by China..
2024/1/1116:00RNSNONHutchmed (China) Limited Sovleplenib NDA Granted Priority..
2023/12/2917:30UKREGHutchmed (China) Limited Total Voting Rights
2023/12/2917:30UKREGHutchmed (China) Limited Blocklisting Six Monthly Return
2023/12/2120:36ALNCNewsIN BRIEF: Hutchmed China renews deals with "substantial"..
2023/12/2119:00UKREGHutchmed (China) Limited Overseas Regulatory Announcement
2023/12/1322:56ALNCNewsHutchmed completes enrolment for fruquintinib trial
2023/12/1316:00RNSNONHutchmed (China) Limited Completed Enrollment of Phase..
2023/12/0719:04UKREGHutchmed (China) Limited Overseas Regulatory Announcement
2023/12/0116:00RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
2023/11/3017:30UKREGHutchmed (China) Limited Total Voting Rights
2023/11/0921:16ALNCNewsHutchmed hails Takeda's fruquintinib approval from US for..
2023/11/0916:00UKREGHutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM)..
2023/10/2417:30UKREGHutchmed (China) Limited Vesting of awards under the LTIP
2023/10/1617:30RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
2023/9/2918:12ALNCNewsHutchmed notes Takeda submits fruquintinib drug application..
2023/9/2917:30UKREGHutchmed (China) Limited Total Voting Rights
2023/9/2917:30RNSNONHutchmed (China) Limited NDA Submission for Fruquintinib in..
2023/9/1417:30UKREGHutchmed (China) Limited Director's Share Dealing
2023/9/1218:26ALNCNewsIN BRIEF: Hutchmed China finalises patient enrolment for..
2023/9/1217:30RNSNONHutchmed (China) Limited Phase IIIb Savolitinib Results at..
2023/9/1215:00RNSNONHutchmed (China) Limited Patient Enrollment Completed for..
2023/8/3117:30UKREGHutchmed (China) Limited Total Voting Rights
2023/8/2917:30ALNCNewsIN BRIEF: China grants Hutchmed's savolitinib breakthrough..
2023/8/2915:00RNSNONHutchmed (China) Limited BTD in China for Savolitinib for..
2023/8/2116:46ALNCNewsHutchmed China hails trial on sovleplenib meeting primary..

最近閲覧した銘柄

Delayed Upgrade Clock